In vitro reversion of amphotericin B resistance in Leishmania donovani by poloxamer 188

Espuelas, S. (Socorro); Legrand, P. (P.); Loiseau, P.M. (P.M.); Bories, C. (C.); Barratt, G. (G.); Irache, J.M. (Juan Manuel)

Autor(es):

Espuelas, S. (Socorro)

Irache, J.M. (Juan Manuel)

Palabras clave :

Leishmania donovani
Poloxamer 188
Amphotericin B Resistance

Fecha de publicación :

2000

Editorial :

American Society for Microbiology

Versión del Editor:

http://aac.asm.org/cgi/content/full/44/8/2190

ISSN :

0066-4804

Cita:

Espuelas S, Legrand P, Loiseau PM, Bories C, Barratt G, Irache JM. In vitro reversion of amphotericin B resistance in leishmania donovani by poloxamer 188. Antimicrob Agents Chemother. 2000 Aug;44(8):2190-2.

Resumen

A micellar formulation of amphotericin B (AmB) solubilized with poloxamer 188 was evaluated against an AmB Leishmania donovani-resistant line. A concave isobologram showed a synergistic effect of this association against promastigotes. This result was confirmed with amastigotes since the 50% effective concentration of the new formulation was 100 times less than that of the control AmB formulation.

URI :

https://hdl.handle.net/10171/19206

Aparece en las colecciones:

DA - Farmacia - Tecnología Farmacéutica - Artículos de revista

Ficheros en este ítem: